NYSE:ANTM - Anthem Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $353.37
  • Forecasted Upside: 9.91 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$321.52
▼ -2.17 (-0.67%)
1 month | 3 months | 12 months
Get New Anthem Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ANTM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ANTM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$353.37
▲ +9.91% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Anthem in the last 3 months. The average price target is $353.37, with a high forecast of $423.00 and a low forecast of $306.00. The average price target represents a 9.91% upside from the last price of $321.52.
Buy
The current consensus among 17 contributing investment analysts is to buy stock in Anthem. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/30/2019
  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/28/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/26/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/21/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/15/2021Jefferies Financial GroupUpgradeHold ➝ Buy$305.00 ➝ $402.00Medium
i
1/13/2021ArgusBoost Price TargetOutperform ➝ Buy$300.00 ➝ $380.00Low
i
1/5/2021TruistBoost Price Target$320.00 ➝ $360.00N/A
i
12/18/2020MizuhoBoost Price TargetNeutral$300.00 ➝ $320.00High
i
12/14/2020SVB LeerinkBoost Price TargetOutperform$370.00 ➝ $400.00Low
i
Rating by D. Ha at SVB Leerink LLC
11/11/2020Piper SandlerBoost Price TargetOverweight$330.00 ➝ $369.00High
i
11/6/2020JPMorgan Chase & Co.Boost Price TargetOverweight$324.00 ➝ $389.00Low
i
10/29/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$349.00 ➝ $337.00Medium
i
10/29/2020Smith Barney CitigroupBoost Price Target$325.00 ➝ $338.00Medium
i
10/29/2020SVB LeerinkBoost Price TargetOutperform$345.00 ➝ $370.00High
i
Rating by D. Ha at SVB Leerink LLC
7/30/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$362.00 ➝ $349.00Low
i
7/30/2020Royal Bank of CanadaBoost Price TargetOutperform$319.00 ➝ $331.00Medium
i
7/30/2020SVB LeerinkBoost Price TargetOutperform$325.00 ➝ $345.00Low
i
Rating by D. Ha at SVB Leerink LLC
7/10/2020Jefferies Financial GroupBoost Price TargetHold$271.00 ➝ $281.00Low
i
7/1/2020SVB LeerinkInitiated CoverageOutperform$325.00Medium
i
Rating by S. Davis at SVB Leerink LLC
6/9/2020Cantor FitzgeraldReiterated RatingBuy$360.00Medium
i
Rating by Steven Halper at Cantor Fitzgerald
6/5/2020The Goldman Sachs GroupInitiated CoverageNeutral$340.00High
i
5/21/2020SunTrust BanksBoost Price TargetHold$280.00 ➝ $320.00Low
i
5/12/2020UBS GroupBoost Price TargetBuy$307.00 ➝ $330.00Low
i
4/30/2020Morgan StanleyBoost Price TargetOverweight$310.00 ➝ $423.00High
i
4/29/2020CfraUpgradeHold ➝ Buy$290.00 ➝ $306.00Medium
i
4/13/2020Morgan StanleyBoost Price TargetOverweight$291.00 ➝ $310.00Low
i
4/13/2020SunTrust BanksLower Price TargetHold$330.00 ➝ $280.00Low
i
4/12/2020Royal Bank of CanadaReiterated RatingBuy$319.00Low
i
4/9/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$257.00Medium
i
3/27/2020Morgan StanleyLower Price TargetBuy$374.00 ➝ $291.00Low
i
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$314.00 ➝ $362.00Medium
i
1/31/2020Morgan StanleyLower Price TargetOverweight$382.00 ➝ $374.00Low
i
1/31/2020Credit Suisse GroupLower Price TargetOutperform$380.00 ➝ $355.00Low
i
1/31/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$319.00 ➝ $314.00Low
i
1/30/2020Bank of AmericaLower Price TargetNeutral$330.00 ➝ $324.00Medium
i
Rating by Kevin Fischbeck at Bank of America Co.
1/29/2020StephensLower Price TargetOverweight$345.00 ➝ $330.00High
i
1/8/2020Credit Suisse GroupBoost Price TargetOutperform$340.00 ➝ $380.00Medium
i
1/3/2020Evercore ISIUpgradeIn-Line ➝ OutperformMedium
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$322.00 ➝ $391.00Medium
i
12/6/2019Bank of AmericaDowngradeBuy ➝ NeutralLow
i
10/24/2019Credit Suisse GroupLower Price TargetOutperform$345.00 ➝ $340.00Low
i
10/17/2019MizuhoInitiated CoverageNeutral$262.00Low
i
9/26/2019Morgan StanleyLower Price TargetOverweight$371.00 ➝ $356.00Low
i
Rating by Zachary Sopcak at Morgan Stanley
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuyLow
i
7/26/2019Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Peter Costa at Wells Fargo & Company
7/12/2019Morgan StanleyBoost Price TargetOverweight$359.00 ➝ $371.00Low
i
5/10/2019CitigroupUpgradeNeutral ➝ Buy$325.00Low
i
4/25/2019BarclaysBoost Price TargetOverweight ➝ Overweight$316.00 ➝ $317.00Medium
i
Rating by Steven Valiquette at Barclays PLC
4/25/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$391.00 ➝ $359.00Medium
i
4/25/2019SunTrust BanksLower Price TargetHold$300.00Medium
i
4/23/2019UBS GroupInitiated CoverageBuy$294.00Medium
i
4/21/2019Cantor FitzgeraldReiterated RatingBuy$360.00Medium
i
Rating by S. Halper at Cantor Fitzgerald
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$338.00 ➝ $316.00Medium
i
Rating by Steven Valiquette at Barclays PLC
3/8/2019BarclaysSet Price TargetBuy$338.00Low
i
Rating by Steven Valiquette at Barclays PLC
3/8/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$344.00 ➝ $368.00Low
i
1/31/2019BarclaysBoost Price TargetOverweight$330.00Low
i
1/31/2019Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$330.00 ➝ $344.00Medium
i
1/31/2019StephensBoost Price TargetOverweight$310.00 ➝ $350.00Medium
i
1/31/2019Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$318.00 ➝ $346.00Medium
i
1/31/2019Morgan StanleyBoost Price TargetOverweight$372.00 ➝ $391.00Medium
i
1/31/2019SunTrust BanksBoost Price Target$340.00Medium
i
1/31/2019Morgan StanleyReiterated RatingOverweight ➝ Overweight$372.00 ➝ $391.00Medium
i
1/24/2019ArgusInitiated CoverageBuy ➝ Buy$333.00Low
i
1/14/2019StephensInitiated CoverageOverweight$310.00Low
i
1/6/2019BarclaysReiterated RatingBuy$282.00Low
i
1/3/2019Evercore ISIUpgradeIn-Line ➝ Outperform$255.02High
i
12/3/2018Cantor FitzgeraldReiterated RatingOverweight ➝ Buy$305.00 ➝ $330.00Medium
i
12/3/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Buy$323.00 ➝ $345.00High
i
11/6/2018CitigroupBoost Price TargetNeutral ➝ Neutral$290.00 ➝ $292.00Low
i
11/1/2018Royal Bank of CanadaBoost Price TargetOutperform$318.00Low
i
11/1/2018SunTrust BanksBoost Price TargetHold$315.00Low
i
11/1/2018Morgan StanleyBoost Price TargetOverweight$368.00 ➝ $372.00Low
i
11/1/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$311.00 ➝ $330.00Low
i
11/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$300.00 ➝ $310.00Medium
i
Rating by Matthew Borsch at BMO Capital Markets
11/1/2018BarclaysReiterated RatingOverweight ➝ Overweight$270.00 ➝ $300.00High
i
10/25/2018Cantor FitzgeraldReiterated RatingBuy$275.00Low
i
10/12/2018Jefferies Financial GroupReiterated RatingBuy$316.00Low
i
9/17/2018CowenInitiated CoverageOutperform$318.00Low
i
9/10/2018CitigroupDowngradeBuy ➝ Neutral$162.00High
i
9/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$273.00 ➝ $368.00Low
i
9/4/2018Credit Suisse GroupBoost Price TargetOutperform$284.00 ➝ $311.00Low
i
7/26/2018Jefferies Financial GroupReiterated RatingBuy$296.00Low
i
7/26/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$269.00 ➝ $273.00Low
i
7/25/2018Cantor FitzgeraldReiterated RatingBuy$275.00High
i
7/9/2018BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$275.00 ➝ $290.00High
i
4/26/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$280.00 ➝ $284.00Medium
i
4/26/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$266.00 ➝ $269.00Medium
i
4/26/2018Sanford C. BernsteinSet Price TargetOutperform$312.00 ➝ $332.00High
i
4/26/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLow
i
4/25/2018Cantor FitzgeraldReiterated RatingBuy$275.00High
i
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$270.00High
i
2/1/2018Credit Suisse GroupReiterated RatingOutperform$255.00 ➝ $280.00Low
i
2/1/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$247.00 ➝ $266.00Low
i
2/1/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $275.00Medium
i
1/31/2018CowenReiterated RatingBuy$280.00Low
i
1/19/2018Cantor FitzgeraldReiterated RatingBuy$275.00Low
i
1/12/2018Jefferies Financial GroupUpgradeHold ➝ Buy$235.00 ➝ $211.00High
i
1/4/2018Royal Bank of CanadaReiterated RatingBuyMedium
i
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$243.00Medium
i
1/3/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$151.00Medium
i
12/6/2017B. RileyReiterated RatingBuy ➝ BuyLow
i
11/17/2017Bank of AmericaBoost Price TargetBuy$249.00 ➝ $254.00N/A
i
11/7/2017SVB LeerinkReiterated RatingOutperformN/A
i
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$234.00N/A
i
10/26/2017Jefferies Financial GroupReiterated RatingHold$226.00N/A
i
10/26/2017Morgan StanleyBoost Price TargetEqual Weight$201.00 ➝ $215.00N/A
i
10/25/2017Cantor FitzgeraldReiterated RatingBuy$220.00N/A
i
Rating by J. France at Cantor Fitzgerald
10/18/2017Cantor FitzgeraldReiterated RatingBuy$215.00N/A
i
Rating by J. France at Cantor Fitzgerald
10/16/2017BMO Capital MarketsInitiated CoverageMarket PerformN/A
i
10/13/2017Jefferies Financial GroupBoost Price TargetHold$204.00 ➝ $211.00N/A
i
10/4/2017Piper Jaffray CompaniesReiterated RatingHold$202.00Low
i
9/21/2017CowenReiterated RatingBuy$160.00Low
i
9/20/2017Cantor FitzgeraldReiterated RatingBuy$215.00Low
i
Rating by J. France at Cantor Fitzgerald
9/14/2017Cantor FitzgeraldReiterated RatingBuy$215.00Low
i
Rating by J. France at Cantor Fitzgerald
8/20/2017Jefferies Financial GroupReiterated RatingHold$204.00Medium
i
8/17/2017Morgan StanleyBoost Price TargetEqual Weight$196.00 ➝ $201.00Low
i
7/26/2017Cantor FitzgeraldReiterated RatingOverweight$210.00 ➝ $215.00Low
i
Rating by J. France at Cantor Fitzgerald
7/14/2017Jefferies Financial GroupReiterated RatingHold$204.00Low
i
7/14/2017Bank of AmericaBoost Price TargetBuy$224.00 ➝ $228.00Low
i
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$173.00 ➝ $185.00Low
i
7/12/2017Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$195.00Low
i
6/28/2017CitigroupReiterated RatingBuy$205.00Low
i
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$196.00Low
i
5/11/2017Cantor FitzgeraldReiterated RatingBuy$136.00Low
i
Rating by J. France at Cantor Fitzgerald
4/28/2017Sanford C. BernsteinBoost Price TargetOutperform$202.00 ➝ $212.00Low
i
4/28/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$166.00 ➝ $173.00Low
i
4/27/2017Cantor FitzgeraldUpgradeHold ➝ Overweight$165.00 ➝ $210.00Low
i
Rating by J. France at Cantor Fitzgerald
4/27/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$179.00 ➝ $183.00Low
i
4/24/2017Cantor FitzgeraldReiterated RatingHold$165.00High
i
4/23/2017Jefferies Financial GroupReiterated RatingHold$177.00 ➝ $183.00Low
i
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$166.00Low
i
3/30/2017Jefferies Financial GroupBoost Price TargetHold$172.00 ➝ $177.00Low
i
3/16/2017UBS GroupReiterated RatingBuy$189.00N/A
i
2/10/2017Royal Bank of CanadaReiterated RatingBuy$179.00N/A
i
2/6/2017Cantor FitzgeraldInitiated CoverageNeutral$165.00N/A
i
2/2/2017UBS GroupReiterated RatingBuy$166.00 ➝ $182.00N/A
i
2/2/2017Jefferies Financial GroupBoost Price TargetHold$151.00 ➝ $172.00N/A
i
2/2/2017Royal Bank of CanadaBoost Price TargetOutperform$169.00 ➝ $174.00N/A
i
2/2/2017BarclaysBoost Price TargetEqual Weight$159.00 ➝ $169.00N/A
i
1/23/2017CitigroupBoost Price TargetBuy$151.00 ➝ $172.00N/A
i
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$151.00N/A
i
1/4/2017Stifel NicolausDowngradeBuy ➝ Hold$143.24 ➝ $155.00N/A
i
12/1/2016Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformN/A
i
12/1/2016Sanford C. BernsteinReiterated RatingOutperform$183.00N/A
i
11/22/2016Wolfe ResearchUpgradeMarket Perform ➝ Outperform$173.00N/A
i
11/15/2016Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformN/A
i
11/6/2016UBS GroupReiterated RatingBuy$162.00 ➝ $160.00N/A
i
11/3/2016SVB LeerinkBoost Price TargetOutperform$155.00 ➝ $160.00N/A
i
11/2/2016Cantor FitzgeraldSet Price TargetHold$125.00N/A
i
10/17/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$154.00 ➝ $132.00N/A
i
9/26/2016SVB LeerinkReiterated RatingBuy$155.00N/A
i
9/22/2016Evercore ISIInitiated CoverageHold$133.00N/A
i
9/13/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$156.00 ➝ $138.00N/A
i
8/31/2016UBS GroupReiterated RatingBuyN/A
i
8/16/2016SVB LeerinkReiterated RatingOutperformN/A
i
8/15/2016(FBRC)Reiterated RatingMarket Perform$155.00N/A
i
7/28/2016Jefferies Financial GroupLower Price TargetBuy$157.00 ➝ $156.00N/A
i
7/28/2016CitigroupLower Price TargetBuy$172.00 ➝ $162.00N/A
i
7/28/2016BarclaysLower Price TargetEqual Weight$158.00 ➝ $151.00N/A
i
7/27/2016WedbushReiterated RatingNeutral$150.00N/A
i
6/29/2016UBS GroupReiterated RatingBuy$180.00N/A
i
6/28/2016Wolfe ResearchInitiated CoverageMarket Perform$168.00N/A
i
6/22/2016UBS GroupReiterated RatingBuy$180.00N/A
i
6/21/2016CitigroupReiterated RatingBuy$172.00N/A
i
6/20/2016WedbushReiterated RatingNeutral$159.00N/A
i
6/16/2016SVB LeerinkReiterated RatingBuy$160.00N/A
i
6/16/2016Sanford C. BernsteinInitiated CoverageOutperform$207.00N/A
i
5/25/2016(FBRC)Reiterated RatingMarket Perform$160.00N/A
i
5/24/2016Sterne Agee CRTDowngradeBuy ➝ NeutralN/A
i
Rating by B. Wright at Sterne Agee CRT
4/28/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
4/28/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Ana Gupte at SVB Leerink LLC
4/8/2016Cleveland ResearchInitiated CoverageBuy$170.00N/A
i
4/5/2016CowenReiterated RatingOutperformN/A
i
4/5/2016UBS GroupReiterated RatingBuy$180.00N/A
i
Rating by A.J. Rice at UBS Group AG
4/1/2016The Goldman Sachs GroupBoost Price TargetBuy$160.00 ➝ $170.00N/A
i
3/31/2016SVB LeerinkReiterated RatingOutperform$190.00 ➝ $195.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
3/22/2016UBS GroupReiterated RatingBuy$180.00N/A
i
Rating by A.J. Rice at UBS Group AG
2/9/2016The Goldman Sachs GroupLower Price Target$168.00 ➝ $160.00N/A
i
1/29/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by David Windley at Jefferies Financial Group Inc.
1/28/2016SVB LeerinkReiterated RatingBuy$200.00 ➝ $190.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
1/28/2016CitigroupReiterated RatingFocus ListN/A
i
1/28/2016Royal Bank of CanadaLower Price TargetOutperform$193.00 ➝ $182.00N/A
i
1/27/2016Cantor FitzgeraldDowngradeHold$150.00N/A
i
1/20/2016The Goldman Sachs GroupUpgradeNeutral ➝ Buy$168.00N/A
i
(Data available from 1/20/2016 forward)
Anthem logo
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2019, it served 41 million medical members through its affiliated health plans. Anthem, Inc. has a strategic relationship with Quest Diagnostics Incorporated to develop various outcomes-based programs for enhanced health care experience for consumers and providers. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $321.52
$317.51
$323.50

50 Day Range

MA: $319.54
$303.30
$338.77

52 Week Range

Now: $321.52
$171.03
$340.98

Volume

1,148,997 shs

Average Volume

1,184,637 shs

Market Capitalization

$79.96 billion

P/E Ratio

16.62

Dividend Yield

1.17%

Beta

1

Frequently Asked Questions

What sell-side analysts currently cover shares of Anthem?

The following Wall Street sell-side analysts have issued reports on Anthem in the last year: Argus, Bank of America Co., Cantor Fitzgerald, Cfra, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Smith Barney Citigroup, Stephens, SunTrust Banks, Inc., SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, and UBS Group AG.

What is the current price target for Anthem?

19 Wall Street analysts have set twelve-month price targets for Anthem in the last year. Their average twelve-month price target is $353.37, suggesting a possible upside of 9.2%. Morgan Stanley has the highest price target set, predicting ANTM will reach $423.00 in the next twelve months. Cfra has the lowest price target set, forecasting a price of $306.00 for Anthem in the next year.

What is the current consensus analyst rating for Anthem?

Anthem currently has 4 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ANTM will outperform the market and that investors should add to their positions of Anthem.

What other companies compete with Anthem?

Other companies that are similar to Anthem include UnitedHealth Group, Cigna, Humana, Centene, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Anthem's investor relations team?

Anthem's physical mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company's listed phone number is 800-331-1476 and its investor relations email address is chris.rigg@anthem.com. The official website for Anthem is www.antheminc.com.